Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $182,119 - $203,291
1,808 Added 27.98%
8,270 $859,000
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $19,166 - $21,168
-175 Reduced 2.64%
6,462 $734,000
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $41,216 - $50,452
457 Added 7.39%
6,637 $730,000
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $141,957 - $170,325
-1,486 Reduced 19.38%
6,180 $598,000
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $33,458 - $37,280
332 Added 4.53%
7,666 $835,000
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $31,963 - $37,623
-330 Reduced 4.31%
7,334 $742,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $78,044 - $91,557
821 Added 12.0%
7,664 $841,000
Q3 2022

Nov 02, 2022

SELL
$96.76 - $112.03 $118,240 - $136,900
-1,222 Reduced 15.15%
6,843 $662,000
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $2,960 - $3,577
29 Added 0.36%
8,065 $876,000
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $24,856 - $30,310
-218 Reduced 2.64%
8,036 $951,000
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $32,579 - $39,891
282 Added 3.54%
8,254 $1.16 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $188,755 - $208,819
-1,618 Reduced 16.87%
7,972 $942,000
Q2 2021

Aug 03, 2021

SELL
$105.79 - $124.53 $65,484 - $77,084
-619 Reduced 6.06%
9,590 $1.11 Million
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $5,877 - $6,924
-54 Reduced 0.53%
10,209 $1.22 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $646,275 - $704,255
6,155 Added 149.83%
10,263 $1.12 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $74,045 - $89,922
-808 Reduced 16.44%
4,108 $447,000
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $308,823 - $451,583
4,916 New
4,916 $388,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Oxford Financial Group LTD Portfolio

Follow Oxford Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.